Financials
- Fiscal year
- 2024
- Total assets
- €361,445
- Profit
- €27,653
- Solvency
- 86.2%
Total assets▼ 39.6%
Net result
20182024
NOVADENT
ActiveSummary
NOVADENT has been active since 1985 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €311,408 and a net result of €27,653. Equity remains stable across the filed fiscal years (±1.4% per year). Its solvency ranks better than 88% of 838 sector peers (NACE 32, fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Manufacture of medical and dental instruments and supplies
NACE 32500
#5 oldest company in Boom, Manufacturing sector3 sites
Size
€361,445total assets 2024
- Staff
- 2.3 FTE
- Equity
- €311,408
- Profit
- €27,653
Turnover not published (abridged schema)
Structure
Accounts 68 days overdue0 of 3 deeds read
Why 91- Figures for FY 2024 (filed 08-10-2025)+ Founded in 1985+ Liquidity: current ratio 4.88, cash €84,976+ Equity €311,408 (86.2% of total assets)Show the evidence
Checked score
Score 2024
91
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 69% of its sector peers (NACE 32, micro)
Financial strength · tick = 2023
Strong
Solvency
100+24
equity 86.2% of total assets
Liquidity
79+41
short-term debt 7.6% · cash 23.5%
Profitability
78+9
return on assets 7.7%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.3%
12-2024: 0.3%● unchanged vs 11-2024
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.4%▲ +0.1 percentage points vs 06-2025
08-2025: 0.6%▲ +0.2 percentage points vs 07-2025
09-2025: 0.6%● unchanged vs 08-2025
10-2025: 0.9%▲ +0.3 percentage points vs 09-2025highest value
11-2025: 0.1%▼ -0.8 percentage points vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026lowest value
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.2%▲ +0.1 percentage points vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 4.88 against 1.31 in 2023; short-term debt: 7.6% and cash: 23.5% of total assets), and 13.8% of the assets are financed with debt.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro): better than 90% on solvency, 78% on liquidity, 61% on profitability and 47% on growth.
The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals.
−lowers risk+raises risk○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 days late
2023
64 days late
2022
32 days late
2021
31 days late
2020
31 days late
2019
98 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 53 days after the deadline; the sector median for financial year 2024 is 2 days before the deadline, and 40% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
- Liquidity quadruplescurrent ratio 4.88
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 13
- Since
- 2016
- 31-12-2023Weakest financial year
- 01-09-2023Annual accounts filed
- 31-08-2022Annual accounts filed
Company details
- Sites
- 3
- Legal form
- Private limited company
- Activity
- Manufacture of medical and dental instruments and suppliesNACE 32500
- Founded
- 21-11-1985
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.